VTYX Overview
Upcoming Projects (VTYX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (VTYX)
-
Discussing Lilly and Ventyx Biosciences' Tamuzimod in patients with moderately-to-severely active ulcerative colitis and VTX958 in moderately to severely active Crohn’s disease
Tickers: VTYX, LLY
Executed On: Mar 04, 2026 at 09:00 AM EST -
Evaluation of Ventyx Biosciences' VTX3232 in Participants with Obesity and Cardiovascular Disease
Tickers: VTYX, LLY
Executed On: Feb 18, 2026 at 03:00 PM EST -
Discussing Ventyx Biosciences' Phase 2a Top-Line Data for VTX3232 in Early-Stage Parkinson’s Disease
Tickers: VTYX, LLY
Executed On: Feb 18, 2026 at 10:00 AM EST -
Digging into S1P1 modulators as treatment for Ulcerative Colitis with a focus on Zeposia (Ozanimod), Etrasimod, CBP-307 & VTX002
Tickers: BMY, PFE, CNTB, VTYX
Executed On: Sep 23, 2022 at 02:00 PM EDT -
A look into the current and developing S1P1 modulators as treatment for Ulcerative Colitis
Tickers: PFE, BMY, CNTB, VTYX
Executed On: Apr 22, 2022 at 01:00 PM EDT
Upcoming & Overdue Catalysts (VTYX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (VTYX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
